Clinical studies in patients with coronary artery disease showed significant reductions in levels of sPLA2 and cholesterol (in low-density lipoprotein), as well as C-reactive protein (CRP) and other biomarkers of inflammation [11,12,13]. This evidence concerns the gene CRP and coronary artery disorder.